Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characterization of subpopulation lacking both B-cell and plasma cell markers in Waldenstrom macroglobulinemia cell line.

Laboratory investigation; a journal of technical methods and pathology - 1 Jan 2014

Wada Naoki, Zhan Maosheng, Hori Yumiko, Honma Keiichiro, Ikeda Jun-ichiro, Morii Eiichi

Abstract excerpt

Cancer cells with tumorigenic potential are limited to a small population known as cancer-initiating cells (CICs). To date, CICs have not been identified in non-Hodgkin's lymphomas. Here, we investigated a candidate of CICs of an indolent non-Hodgkin's lymphoma, Waldenstrom macroglobulinemia (WM), using WM cell line MWCL-1. WM tumor expresses both B-cell and plasma cell markers, CD20 and CD138. When stained with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, CD20
Share to Cellular Senescence

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Forkhead Box Protein O3

Share to Forkhead Transcription Factors

Share to Immunophenotyping

Share to Reactive Oxygen Species

Share to Syndecan-1

Share to Waldenstrom Macroglobulinemia

Source

Identifiers

PMID: 24189269
DOI: 10.1038/labinvest.2013.129

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characterization of subpopulation lacking both B-cell and plasma cell markers in Waldenstrom macroglobulinemia cell line.PMID 24189269Read ↗

Waldenström's macroglobulinemia: Two malignant clones in a monoclonal disease? Molecular background and clinical reflection.Semantic proximity Read ↗

Development and characterization of a novel human Waldenström macroglobulinemia cell line: RPCI-WM1, Roswell Park Cancer Institute - Waldenström Macroglobulinemia 1.Semantic proximity Read ↗

Expanded tumor-associated polymorphonuclear Myeloid-derived suppressor cells in Waldenstrom macroglobulinemia display immune suppressive activitySemantic proximity Read ↗

The Wayne State University Waldenstrom's Macroglobulinemia preclinical model for Waldenstrom's macroglobulinemia.Semantic proximity Read ↗

Role of plasma cells in Waldenström macroglobulinaemia.Semantic proximity Read ↗

Gene Expression Profiling Reveals Aberrant T-cell Marker Expression on Tumor Cells of Waldenström's MacroglobulinemiaSemantic proximity Read ↗

Phenotypic Profile of Waldenström Macroglobulinaemia B-Cells: Establishment of a Diagnosis Scoring System and Clinico-Biological Correlations.Semantic proximity Read ↗

Characterization of clonogenic multiple myeloma cellsSemantic proximity Read ↗

Rare transformation to double hit lymphoma in Waldenstrom's macroglobulinemia.Semantic proximity Read ↗

Associated malignancies in patients with Waldenström's macroglobulinemia and their kin.Semantic proximity Read ↗

Familial predisposition to monoclonal gammopathy of unknown significance, Waldenström's macroglobulinemia, and multiple myeloma.Semantic proximity Read ↗

Survival Trends in Waldenström Macroglobulinemia and Comparison of Outcomes with the General US PopulationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.